This content is machine translated Biologics in rheumatology Additional therapeutic option available for psoriatic arthritis [1]. Psoriatic arthritis (PsA) affects about one in three patients with psoriasis and, if left untreated, can lead to severe physical limitations and a reduced quality of life [2,3]. With the…
View Post 6 min This content is machine translated Rheumatic diseases Modern management of axial spondyloarthritis For patients with axial spondyloarthritis (axSpA), in whom therapy with non-steroidal anti-inflammatory drugs was not effective, several active agents from the substance classes of biologics and JAK inhibitors are available…
View Post 6 min This content is machine translated ILD in sclerosis, RA and idiopathic myopathies. Antifibrotics and biologics as alternatives to steroids Interstitial lung disease (ILD) can occur as a complication of several connective tissue diseases, and increased mortality and morbidity are the consequences. ILD is thought to be driven by immune-mediated…
View Post 5 min This content is machine translated Rheumatoid arthritis Smart technology promotes self-management Digitization in healthcare holds many opportunities, especially for disease management of chronic diseases. When digital applications are integrated into a personalized and long-term treatment plan, it can help improve care…
View Post 5 min This content is machine translated Pain Management Living at last – on the track of the individually best therapy Improving care in pain and palliative situations was the focus of this year’s Pain Congress. Patients with chronic pain in particular require individualized treatment in order to finally be able…
View Post 5 min This content is machine translated Pain therapy for rheumatic inflammatory diseases It doesn’t always have to be an opioid For patients with rheumatic diseases, pain is the central problem. However, recent studies show that influencing pain experience with biologics is possible and that JAK inhibitors can provide rapid, direct…
View Post 4 min This content is machine translated Personalized therapy in RA Targeting instead of MTX for all “It is more important to know which person has a disease than to know which disease a person has” – this sentence is attributed to Hippocrates, which means that the…
View Post 4 min This content is machine translated Multiple sclerosis The role of astrocytes in progress management. In chronic neurodegenerative diseases such as multiple sclerosis, CNS cells make various adaptations during neuroinflammation. The main cells involved in this inflammatory process are the glial cells, among which the…
View Post 3 min This content is machine translated Routine care for psoriasis Update system therapy – what is important for the practice? The new treatment options lead to higher therapeutic goals. This is also reflected in the current psoriasis guideline, which received an update last year. The determination of the severity is…
View Post 6 min This content is machine translated Systemic Lupus Erythematosus New weapons in the fight against SLE Systemic Lupus Erythematosus (SLE) is often a major challenge not only for those affected, but also for physicians. Despite numerous therapeutic options, treatment is usually a tightrope walk between dangerous…
View Post 4 min This content is machine translated Psoriasis and psoriatic arthritis Secukinumab as a treatment option in pediatric patients – an update. Children and adolescents affected by psoriasis and/or psoriatic arthritis often suffer a great deal. Particularly in cases of severe symptoms, the quality of life of those affected and their families…
